Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta in adults with ADHD
NCT00783835Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate osmotic release oral system in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical. Primary endpoints: Adult ADHD Self-Report Scale Total Score at 12 weeks and Adult ADHD Quality of Life Scale Score at 12 weeks. Started Feb 2008; status: completed.
02
Drugs
methylphenidate osmotic release oral system
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00783835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783835.